These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 25444293)

  • 1. Revolution then evolution: the advance of health economic evaluation in Australia.
    Lopert R; Viney R
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):360-6. PubMed ID: 25444293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of economic evaluation for guiding the pharmaceutical reimbursement list in Thailand.
    Teerawattananon Y; Tritasavit N; Suchonwanich N; Kingkaew P
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):397-404. PubMed ID: 25444298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health economic evaluations in reimbursement decision making in the Netherlands: time to take it seriously?
    Franken M; Koopmanschap M; Steenhoek A
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):383-9. PubMed ID: 25444296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of health economic evaluations in Sweden.
    Heintz E; Arnberg K; Levin LÅ; Liliemark J; Davidson T
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):375-82. PubMed ID: 25444295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health economic evaluation in England.
    Raftery J
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):367-74. PubMed ID: 25444294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decision making in Germany: is health economic evaluation as a supporting tool a sleeping beauty?
    Gerber-Grote A; Sandmann FG; Zhou M; Ten Thoren C; Schwalm A; Weigel C; Balg C; Mensch A; Mostardt S; Seidl A; Lhachimi SK
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):390-6. PubMed ID: 25444297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How health economic evaluation (HEE) contributes to decision-making in public health care: the case of Brazil.
    Elias FT; Araújo DV
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):405-12. PubMed ID: 25444299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health resource allocation. A made-in-Canada description.
    Noseworthy T
    J Leg Med; 2011 Jan; 32(1):11-26. PubMed ID: 21391053
    [No Abstract]   [Full Text] [Related]  

  • 9. Economic evaluation for pharmaceuticals in Germany.
    Jönsson B
    Eur J Health Econ; 2007 Sep; 8 Suppl 1():S1-2. PubMed ID: 17638033
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence-based decision-making within Australia's pharmaceutical benefits scheme.
    Lopert R
    Issue Brief (Commonw Fund); 2009 Jul; 60():1-13. PubMed ID: 19639714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health technology assessment in India: the potential for improved healthcare decision-making.
    Kumar M; Ebrahim S; Taylor FC; Chokshi M; Gabbay J
    Natl Med J India; 2014; 27(3):159-63. PubMed ID: 25668089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A changing medical and economic world: complex diseases and interest in economic evaluation of health technologies].
    Hiligsmann M; Reginster JY
    Rev Med Liege; 2012; 67(5-6):258-62. PubMed ID: 22891476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the contribution of health economic evaluations to decision-making in health care? Experiences from 7 selected countries.
    Gerber-Grote A; Windeler J
    Z Evid Fortbild Qual Gesundhwes; 2014; 108(7):358-9, 355-7. PubMed ID: 25444292
    [No Abstract]   [Full Text] [Related]  

  • 14. Economic evaluation of medical technologies: from theory to practice--the German perspective.
    Graf von der Schulenburg JM
    Soc Sci Med; 1997 Aug; 45(4):621-33. PubMed ID: 9226786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical economy and the economic assessment of drugs in France.
    le Pen C
    Soc Sci Med; 1997 Aug; 45(4):635-43. PubMed ID: 9226787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug policy down under: Australia's pharmaceutical benefits scheme.
    Duckett SJ
    Health Care Financ Rev; 2004; 25(3):55-67. PubMed ID: 15229996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International diffusion of new health technologies: a ten-country analysis of six health technologies.
    Packer C; Simpson S; Stevens A;
    Int J Technol Assess Health Care; 2006; 22(4):419-28. PubMed ID: 16984674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health technology assessment and economic evaluation across jurisdictions.
    Simoens S
    Value Health; 2010; 13(6):857-9. PubMed ID: 20701730
    [No Abstract]   [Full Text] [Related]  

  • 19. Approaches for economic evaluations of health care technologies.
    Tarride JE; Blackhouse G; Bischof M; McCarron EC; Lim M; Ferrusi IL; Xie F; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):307-16. PubMed ID: 19394571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Values and evidence colliding: health technology assessment in child health.
    Ungar WJ; Prosser LA; Burnett HF
    Expert Rev Pharmacoecon Outcomes Res; 2013 Aug; 13(4):417-9. PubMed ID: 23977967
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 23.